Megan Boxall

Is Pfizer’s announcement a shot in the arm for markets or a stab in the dark?

Daily updates as the results roll in

Four scenarios to consider in the wake of the closest election in a generation

With less than a week to go until polling day, US media outlets are braced for a challenge

Megan Boxall and John Hughman explain how private companies are key to the survival of the NHS

Third quarter fail to reflect the confidence of the famed fund manager

Is now as good as it gets for Apple investors?

Barry Norris lays down his argument for why he’s shorting pharma companies

The race to find a vaccine is at the heart of the Republican campaign

The 2000 years it took to develop the world’s first vaccine should temper expectations for an imminent coronavirus breakthrough